AstroNova, Inc. (NASDAQ:ALOT – Get Rating) saw a large decline in short interest during the month of December. As of December 30th, there was short interest totalling 10,400 shares, a decline of 6.3% from the December 15th total of 11,100 shares. Approximately 0.2% of the company’s stock are short sold. Based on an average daily volume of 5,900 shares, the short-interest ratio is currently 1.8 days.
AstroNova Price Performance
Shares of NASDAQ:ALOT opened at $13.99 on Wednesday. The company has a quick ratio of 0.75, a current ratio of 1.96 and a debt-to-equity ratio of 0.16. AstroNova has a fifty-two week low of $10.97 and a fifty-two week high of $15.98. The firm has a 50-day simple moving average of $12.35 and a 200 day simple moving average of $12.15. The company has a market cap of $102.83 million, a PE ratio of 174.90 and a beta of 0.60.
AstroNova (NASDAQ:ALOT – Get Rating) last announced its quarterly earnings data on Wednesday, December 7th. The business services provider reported $0.11 earnings per share for the quarter. AstroNova had a net margin of 0.41% and a return on equity of 1.33%. The business had revenue of $39.41 million during the quarter.
Institutional Investors Weigh In On AstroNova
Wall Street Analyst Weigh In
Separately, StockNews.com started coverage on shares of AstroNova in a research report on Tuesday. They issued a “strong-buy” rating for the company.
AstroNova Company Profile
AstroNova, Inc engages in the design, development, manufacture, and distribution of specialty printers and data acquisition and analysis systems. It operates through the Product Identification (PI) and Test and Measurement (T&M) segments. The PI segment offers digital label printers, over-printers, labeling software, spare parts, service contracts, and related printing supplies such as pressure sensitive labels, tags, inks, toners, and thermal transfer ribbons used in product identification digital printers.
- Get a free copy of the StockNews.com research report on AstroNova (ALOT)
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- Is It Time To Get Aggressive With Defense Stocks?
- 3 Retail Stocks Ringing the Register in 2023
Receive News & Ratings for AstroNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AstroNova and related companies with MarketBeat.com's FREE daily email newsletter.